
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study
Auteurs Elia Gigante, Mohamed Bouattour, José Ursic Bedoya, Hélène Regnault, Marianne Ziol, Eric Assenat, Valérie Paradis, Julien Calderaro, Nathalie Ganne-Carrié, Karine Bouhier-Leporrier, Giuliana Amaddeo and
